Literature DB >> 11829294

Evaluating the crash and citation rates of Utah drivers licensed with medical conditions, 1992-1996.

Donald D Vernon1, Edma M Diller, Lawrence J Cook, James C Reading, Anthony J Suruda, J Michael Dean.   

Abstract

BACKGROUND: Medical problems may affect the ability to drive motor vehicles, and programs that control the issuing of driver licenses to individuals with medical conditions exist in most states. The main activity of these programs is the imposition of restrictions upon the driving privileges of individuals with medical conditions that are deemed to pose some risk to public safety. However, little is known about the effectiveness of these licensing programs.
OBJECTIVE: The objective of this study was to compare the rates of adverse driving events (crash, at-fault crash and citations) experienced by drivers licensed with medical conditions to those of age-, sex- and location-matched controls. Separate comparisons were made for drivers reporting medical conditions licensed with full driving privileges, and those with restricted driving privileges (e.g. speed, area and time of day).
DESIGN: Retrospective case-control.
METHODS: The study population was all drivers licensed in the state of Utah who reported a medical condition on their driver license application, over the 5-year period 1992-1996. Drivers enter the program by self-reporting their medical problems. Control drivers were chosen from the entire population of drivers licensed in Utah for the same period. Information on driver license status, participation in the medical conditions program, citations, involvement in crashes, and death certificate data was obtained from the relevant state agencies. Probabilistic linkage methodology was used to link the records in these disparate databases for eventual analysis. Rates of citation, crashes and at-fault crashes, expressed as events per 10000 license days, were calculated separately for program drivers and their corresponding control groups for each medical condition category and restriction status. These data were used to determine an estimate of relative risk (RR) and 95% confidence intervals.
RESULTS: As a group, medical conditions drivers had modestly elevated rates of adverse driving events compared with control drivers (RR 1.09-1.74). Rates in the largest medical category, 'cardiovascular conditions', were not higher than controls. Rates were higher than control for some conditions, such as 'alcohol' and 'learning and memory', for some adverse events (RR 2.2 -5.75). Drivers with more than one medical condition appeared comparable to the general group of medical conditions program drivers.
CONCLUSIONS: Drivers in Utah medical conditions program had modestly elevated rates of adverse driving events compared to matched controls. Possible underreporting of medical conditions and accurate assessment of exposure rates are potential weaknesses in the program.

Entities:  

Mesh:

Year:  2002        PMID: 11829294     DOI: 10.1016/s0001-4575(01)00019-7

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  5 in total

Review 1.  Medical interventions to reduce motor vehicle collisions.

Authors:  Donald A Redelmeier; Homer C Tien
Journal:  CMAJ       Date:  2013-12-09       Impact factor: 8.262

2.  Crash rates of quebec drivers with medical conditions.

Authors:  Jamie Dow; Michel Gaudet; Emilie Turmel
Journal:  Ann Adv Automot Med       Date:  2013

Review 3.  Epilepsy and driving: potential impact of transient impaired consciousness.

Authors:  William C Chen; Eric Y Chen; Rahiwa Z Gebre; Michelle R Johnson; Ningcheng Li; Petr Vitkovskiy; Hal Blumenfeld
Journal:  Epilepsy Behav       Date:  2014-01       Impact factor: 2.937

Review 4.  Seizure-related injuries, drowning and vehicular crashes -- a critical review of the literature.

Authors:  Michael Tan; Wendyl D'Souza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

5.  Work stress and health problems of professional drivers: a hazardous formula for their safety outcomes.

Authors:  Sergio A Useche; Boris Cendales; Luis Montoro; Cristina Esteban
Journal:  PeerJ       Date:  2018-12-20       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.